Bitten by the Bug – A flurry of investments fuel microbiome drug discovery
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Animal models, Business, Cell therapy, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene therapy, Immunology, Immunology / Virology & Vaccines, Lead discovery, Microbiology, Microbiome, Oncology, Preclinical, Stem cells, System biology, Target validation, Therapeutics, Toxicology, Translational, Translational chemistry
